Key result
BMIPP SPECT shows reduced uptake vs 201Tl in 40% of HCM segments, correlating with LVEF.
Why the study?
Discrepancies between myocardial perfusion and fatty acid metabolism in hypertrophic cardiomyopathy were not well characterized, and the utility of BMIPP as a tracer for left ventricular function assessment was unclear.
Does 123I-BMIPP SPECT imaging reveal discrepancies in fatty acid metabolism compared to 201Tl perfusion and correlate with left ventricular function in patients with hypertrophic cardiomyopathy?
Comparison
201Tl vs 123I-beta-methylpentadecanoic acid (BMIPP) myocardial uptake
Design
Cross-sectional myocardial SPECT imaging study
Authors
Loading...
May support BMIPP SPECT for metabolic assessment in HCM; leaves open clinical adoption pending prospective validation.
Cross-Sectional (n=17)
Does 123I-BMIPP SPECT imaging reveal discrepancies in fatty acid metabolism compared to 201Tl perfusion and correlate with left ventricular function in patients with hypertrophic cardiomyopathy?
Effect estimate: r = 0.748
p-value: p=< 0.01
BMIPP SPECT imaging demonstrates impaired fatty acid metabolism in hypertrophic cardiomyopathy and serves as a useful tracer for assessing left ventricular function.
SHIMONAGATA et al. (1993) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=17). 123I-BMIPP SPECT vs. 201Tl SPECT was evaluated on Correlation between BMIPP perfusion score and left ventricular ejection fraction (r = 0.748, p=< 0.01). BMIPP SPECT showed reduced uptake compared to 201Tl in 40% of myocardial segments in HCM patients and significantly correlated with left ventricular ejection fraction (r=0.748; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: